CREDIT SUISSE AG/ - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 37 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q3 2016. The put-call ratio across all filers is 16.09 and the average weighting 0.0%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q4 2016$7,000
-85.7%
14,000
-80.0%
0.00%
Q3 2016$49,000
-56.2%
70,000
+24.2%
0.00%
Q2 2016$112,000
+14.3%
56,346
+38.1%
0.00%
Q1 2016$98,000
+27.3%
40,801
+308.0%
0.00%
Q4 2015$77,000
-65.8%
10,001
-60.2%
0.00%
Q2 2015$225,000
+12.5%
25,099
+29.6%
0.00%
Q4 2013$200,00019,3700.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q3 2016
NameSharesValueWeighting ↓
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,227,832$856,0000.04%
FT Options LLC 15,000$10,0000.01%
BLUESTEIN R H & CO LLC 112,200$78,0000.01%
SABBY MANAGEMENT, LLC 203,097$142,0000.01%
TWO SIGMA SECURITIES, LLC 16,701$12,0000.00%
Klingman & Associates, LLC 10,000$7,0000.00%
TFS CAPITAL LLC 13,627$10,0000.00%
OPPENHEIMER & CO INC 75,500$53,0000.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 103,900$72,0000.00%
Virtu KCG Holdings LLC 48,827$34,0000.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders